Chandra Bhattacharya

Assistant Professor of Medicinal Chemistry
Expertise: Organic chemistry, Chemical biology, Medicinal chemistry, Drug and gene delivery, Glycochemistry, Glycobiology, Biomaterials

Biography

Medicinal chemist Chandra Bhattacharya is an assistant professor with UNLV's College of Sciences and founder of the university's messenger RNA (mRNA Nanomedicine Program. Her research interfaces  with the disciplines of bioengineering and drug delivery.

Bhattacharya has also explored personalized medicine, using carbohydrates and small molecules to target organs and cells to deliver mRNA. For example, her most recent projects have used detective work to crack the code for blood cancer and diabetes therapy — developing a nanoparticle, which could encase and protect the mRNA to make it possible to be administered as an injection that interacts with our immune systems' T-cells and immediately responds to cell changes in real time. The goal is to create revolutionary solutions that, unlike current treatment methods, are inexpensive and have a high success rate.

For her work on the development of glucose-responsive material for smart insulin, Bhattacharya received the Postdoctoral Fellowship Juvenile Diabetes Research Foundation (JDRF) Postdoctoral Fellowship. She is also an inventor who holds several patents related to her tumor research.

Education

  • Postdoc, Bioengineering, Massachusetts Institute of Technology (MIT)
  • Ph.D., Organic and Bioorganic Chemistry, Arizona State University
  • MSc., Chemistry, Indian Institute of Technology Kharagpur, India
  • BSc., Chemistry, Presidency College, India

Search For Other Experts On

health & medicine, science & technology

Chandra Bhattacharya In The News

Earth.com
A new study reports nanoparticles that send messenger RNA, genetic instructions that tell cells to make proteins, directly to the pancreas with 99 percent selectivity.
K.L.A.S. T.V. 8 News Now
A research team at the University of Nevada, Las Vegas claims its latest discovery could eventually lead to curing pancreatic cancer and diabetes.
Science Mag
A groundbreaking development in mRNA delivery techniques has emerged from researchers at the University of Nevada, Las Vegas (UNLV), promising to transform treatments for diseases related to the pancreas, including both diabetes and pancreatic cancer.
PhRMAFoundation
Chandrabali Bhattacharya, PhD, of the University of Nevada, Las Vegas, is developing a platform for in vivo CAR T cell therapy, which could have a tremendous impact on the field of cancer immunotherapy.

Articles Featuring Chandra Bhattacharya

Fall colors 2025
Campus News | November 10, 2025

Some of the biggest news headlines featuring UNLV faculty and students.

First day of classes.
Campus News | September 9, 2025

The top news stories starring university students and staff.

Messenger RNA
Research | August 26, 2025

UNLV research team develops mRNA cocktail to intravenously and directly reach the pancreas, allowing for potentially revolutionary treatment options; lead researcher Chandra Bhattacharya becomes university's first to earn national award. 

UNLV professor Chandra Bhattacharya
Research | August 22, 2023

UNLV biochemist Chandra Bhattacharya is unlocking clues for treatment of cancer and other diseases; answer may lie in mRNA.